Day One Biopharmaceuticals I logo

Day One Biopharmaceuticals I share price today

(DAWN)

Day One Biopharmaceuticals I share price is $12.79 & ₹1,086.84 as on 21 Dec 2024, 2.30 'hrs' IST

$12.79

0.33

(2.65%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Day One Biopharmaceuticals I share price in Dollar and Rupees. Guide to invest in Day One Biopharmaceuticals I from India. Also see the sentimental analysis on Indian investors investing in Day One Biopharmaceuticals I. Get details on the Indian mutual funds that are investing in Day One Biopharmaceuticals I. Get Analyst recommendations and forecasts along with all the Day One Biopharmaceuticals I's financials.

Day One Biopharmaceuticals I share price movements

  • Today's Low: $12.11
    Today's High: $12.98

    Day's Volatility :6.7%

  • 52 Weeks Low: $11.94
    52 Weeks High: $18.07

    52 Weeks Volatility :33.92%

Day One Biopharmaceuticals I Returns

PeriodDay One Biopharmaceuticals ISector (Health Care)Index (Russel 2000)
3 Months
-10.31%
-11.1%
0.0%
6 Months
-5.47%
-6.0%
0.0%
1 Year
-14.9%
2.7%
0.0%
3 Years
-18.27%
0.6%
-19.7%

Day One Biopharmaceuticals I Key Statistics

in dollars & INR

Previous Close
$12.46
Open
$12.37
Today's High
$12.98
Today's Low
$12.11
Market Capitalization
$1.3B
Today's Volume
$2.2M
52 Week High
$18.0699
52 Week Low
$11.94
Revenue TTM
$102.0M
EBITDA
$-205.5M
Earnings Per Share (EPS)
$-0.97
Profit Margin
-82.68%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-17.84%

How to invest in Day One Biopharmaceuticals I from India?

It is very easy for Indian residents to invest directly in Day One Biopharmaceuticals I from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Day One Biopharmaceuticals I stock in both Indian Rupees (INR) and US Dollars (USD). Search for Day One Biopharmaceuticals I or DAWN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Day One Biopharmaceuticals I or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Day One Biopharmaceuticals I shares which would translate to 0.066 fractional shares of Day One Biopharmaceuticals I as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Day One Biopharmaceuticals I, in just a few clicks!

Returns in Day One Biopharmaceuticals I for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Day One Biopharmaceuticals I investment value today

Current value as on today

₹1,17,100

Returns

₹17,100

(+17.1%)

Returns from Day One Biopharmaceuticals I Stock

₹14,904 (false-14.9%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Day One Biopharmaceuticals I

54%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Day One Biopharmaceuticals I on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 54% more investors are searching Day One Biopharmaceuticals I in the last 30 days versus the previous period.

Global Institutional Holdings in Day One Biopharmaceuticals I

  • RA Capital Management, LLC

    7.81%

  • FMR Inc

    7.35%

  • Vanguard Group Inc

    5.84%

  • BRAIDWELL LP

    4.83%

  • BlackRock Inc

    4.50%

  • Franklin Resources Inc

    3.84%

Analyst Recommendation on Day One Biopharmaceuticals I

Buy

    82%Buy

    11%Hold

    5%Sell

Based on 17 Wall street analysts offering stock ratings for Day One Biopharmaceuticals I(by analysts ranked 0 to 5 stars)

Based on 17 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
14
14
14
Hold
2
2
2
Sell
1
1
1

Analyst Forecast on Day One Biopharmaceuticals I

What analysts predicted

Upside of 184.94%

Current:

$12.79

Target:

$36.44

Insights on Day One Biopharmaceuticals I

  • Price Movement

    In the last 7 days, DAWN stock has moved up by 0.3%
  • DAWN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 45.6%
  • DAWN vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 49.0%
  • Price to Sales

    ForDAWN every $1 of sales, investors are willing to pay $11.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.9 for every $1 of sales.

Day One Biopharmaceuticals I Technicals Summary

Sell

Neutral

Buy

Day One Biopharmaceuticals I is currently in a neutral trading position according to technical analysis indicators.

Day One Biopharmaceuticals I Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Day One Biopharmaceuticals I
-4.12%
-5.47%
-14.9%
-18.27%
-41.2%
Regeneron Pharmaceuticals, Inc.
-5.73%
-34.03%
-17.11%
13.66%
87.56%
Biontech Se
4.48%
30.56%
7.36%
-56.46%
225.6%
Alnylam Pharmaceuticals, Inc.
-0.55%
10.11%
28.49%
30.99%
109.19%
Vertex Pharmaceuticals Incorporated
-11.79%
-16.36%
-1.97%
78.33%
80.59%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Day One Biopharmaceuticals I
3.54
NA
NA
-0.81
-0.18
-0.25
NA
5.51
Regeneron Pharmaceuticals, Inc.
17.51
17.51
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.55
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Day One Biopharmaceuticals I
Buy
$1.3B
-41.2%
3.54
-82.68%
Regeneron Pharmaceuticals, Inc.
Buy
$77.8B
87.56%
17.51
33.61%
Biontech Se
Buy
$26.7B
225.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.8B
109.19%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$102.1B
80.59%
32.84
-4.51%

About Day One Biopharmaceuticals I

day one biopharmaceuticals understands that advances in cancer research now enable drug developers to identify children and adults who may benefit from the same medicine. we are a unique company created to find and develop new therapies that meet the critical needs of people of all ages living with cancer – starting from the biology of childhood cancer. our distinctive approach, together with our trusted network of pediatric oncology investigators, gives us an unparalleled ability to advance promising discoveries for patients of any age. we are ready to pursue the full potential of our therapies to improve the greatest number of lives as quickly as possible.
Organization
Day One Biopharmaceuticals I
Employees
174
CEO
Dr. Jeremy Bender M.B.A., Ph.D.
Industry
Healthcare

Management People of Day One Biopharmaceuticals I

NameTitle
Dr. Jeremy Bender M.B.A., Ph.D.
CEO, President & Director
Dr. Samuel C. Blackman M.D., Ph.D.
Co-Founder and Head of R&D
Mr. Charles N. York II, M.B.A.
COO, CFO & Secretary
Mr. Adam Dubow J.D.
General Counsel and Chief Compliance Officer
Mr. John Stubenrauch Ph.D.
Chief Technology Officer
Ms. Jaa Roberson
Chief People Officer
Dr. Davy Chiodin Ph.D., Pharm.D.
Chief Development Officer
Ms. Lauren Merendino M.B.A.
Chief Commercial Officer
Dr. Elly Barry M.D.
Chief Medical Officer

Important FAQs about investing in Day One Biopharmaceuticals I from India :

What is Day One Biopharmaceuticals I share price today?

Day One Biopharmaceuticals I share price today stands at $12.79, Open: $12.37 ; Previous Close: $12.46 ; High: $12.98 ; Low: $12.11 ; 52 Week High: $18.07 ; 52 Week Low: $11.94. The stock opens at $12.37, after a previous close of $12.46. The stock reached a daily high of $12.98 and a low of $12.11, with a 52-week high of $18.07 and a 52-week low of $11.94.

Can Indians buy Day One Biopharmaceuticals I shares?

Yes, Indians can invest in the Day One Biopharmaceuticals I (DAWN) from India.

With INDmoney, you can buy Day One Biopharmaceuticals I at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Day One Biopharmaceuticals I at zero transaction cost.

How can I buy Day One Biopharmaceuticals I shares from India?

It is very easy to buy Day One Biopharmaceuticals I from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Day One Biopharmaceuticals I be purchased?

Yes, you can buy fractional shares of Day One Biopharmaceuticals I with INDmoney app.

What are the documents required to start investing in Day One Biopharmaceuticals I stocks?

To start investing in Day One Biopharmaceuticals I, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Day One Biopharmaceuticals I

Today’s highest price of Day One Biopharmaceuticals I (DAWN) is $12.98.

Today’s lowest price of Day One Biopharmaceuticals I (DAWN) is $12.11.

What is today's market capitalisation of Day One Biopharmaceuticals I

Today's market capitalisation of Day One Biopharmaceuticals I DAWN is 1.3B

What is the 52 Week High and Low Range of Day One Biopharmaceuticals I

  • 52 Week High

    $18.07

  • 52 Week Low

    $11.94

What are the historical returns of Day One Biopharmaceuticals I?

  • 1 Month Returns

    -4.12%

  • 3 Months Returns

    -5.47%

  • 1 Year Returns

    -14.9%

  • 5 Years Returns

    -41.2%

Who is the Chief Executive Officer (CEO) of Day One Biopharmaceuticals I

Dr. Jeremy Bender M.B.A., Ph.D. is the current Chief Executive Officer (CEO) of Day One Biopharmaceuticals I.